Tertiary lymphoid structures in cervical cancer have started to be studied intensively in the last two years, which has been closely related to the implementation of PDL-1 therapies, which are already applied in other types of malignancies but not in cervical cancer. Here, CD274 is linked to cervical carcinoma.